本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Recursion Pharmaceuticals, Inc.

5.41
-0.0900-1.64%
盘后5.430.0200+0.37%18:18 EDT
成交量:1,352.14万
成交额:7,329.98万
市值:21.76亿
市盈率:-3.20
高:5.65
开:5.35
低:5.28
收:5.50
数据加载中...
2024/12/04

关联方拟减持公告

Form 144 | RECURSION PHARMACEUTICALS, INC. 高管 Gibson Christopher 拟减持20000股,总价约14.32万美元
2024/12/03

重要事件披露

Form 8-K - Current report
2024/11/27

重要事件披露

Form 8-K/A - Current report: [Amend]
2024/11/26

重要事件披露

Form 8-K/A - Current report: [Amend]
2024/11/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/20

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/11/20

重要事件披露

Form 8-K - Current report
2024/11/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/13

重要事件披露

Form 8-K - Current report
2024/11/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/13

重要事件披露

Form 8-K - Current report
2024/11/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/06

重要事件披露

Form 8-K - Current report
2024/11/06

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/06

重要事件披露

Form 8-K - Current report
2024/11/04

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/10/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities